Position in ATYR
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$32,835
-$45,165 QoQ
Shares Held
55,000
-45.0% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 90 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ATYR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HOHIMER WEALTH MANAGEMENT, LLC holds $8,657,709 across 7 Biotechnology names. ATYR ranks #6 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SMMT |
Summit Therapeutics Inc.
|
339,100 | $4,940,687 | |
| 2 | ACAD |
Acadia Pharmaceuticals Inc
|
91,800 | $2,322,540 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,530 | $759,996 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
1,038 | $385,793 | |
| 5 | INVA |
Innoviva, Inc.
|
9,505 | $215,858 | |
| 6 | ATYR |
aTYR PHARMA INC
This page
|
55,000 | $32,835 | |
| 7 | 11,033 | $0 |
All Filings in ATYR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,835 | 55,000 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $78,000 | 100,000 | Shares | Sole | 2026-05-01 | |
| No filing history on record for this holder in this stock. | ||||||